Literature DB >> 18706002

Polypill: for Pollyanna.

J David Spence1.   

Abstract

A single pill containing a statin, thiazide diuretic, beta-blocker, angiotensin receptor antagonist, folate and ASA has been proposed for all people over age 55, with the aim of reducing cardiovascular disease by 80%. Unfortunately, there are insurmountable problems with choosing appropriate constituents of any such single remedy. Adverse effects, drug interactions, inter-individual variation in drug metabolism, and underlying causes of hypertension that differ between patients require individualized therapy. A single pill that will succeed in all patients is not only practically, but conceptually, an inappropriate approach for the prevention of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706002     DOI: 10.1111/j.1747-4949.2008.00169.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  4 in total

Review 1.  Polypill: lights and shadows.

Authors:  Koon K Teo; Yan Liang
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 2.  Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.

Authors:  Mohamed A Alhnan; Tochukwu C Okwuosa; Muzna Sadia; Ka-Wai Wan; Waqar Ahmed; Basel Arafat
Journal:  Pharm Res       Date:  2016-05-18       Impact factor: 4.200

Review 3.  Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.

Authors:  Mohammad A Azad; Deborah Olawuni; Georgia Kimbell; Abu Zayed Md Badruddoza; Md Shahadat Hossain; Tasnim Sultana
Journal:  Pharmaceutics       Date:  2020-02-03       Impact factor: 6.321

Review 4.  Intensive risk factor control in stroke prevention.

Authors:  J David Spence
Journal:  F1000Prime Rep       Date:  2013-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.